Investors Interested In MiMedx Group, Inc.'s (NASDAQ:MDXG) Earnings

Simply Wall St.01-09

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may consider MiMedx Group, Inc. (NASDAQ:MDXG) as a stock to potentially avoid with its ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2602215320?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","is_english":true,"pubTime":"2026-01-09 19:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602215320","market":"hk","top_or_hot":-1,"title":"Investors Interested In MiMedx Group, Inc.'s (NASDAQ:MDXG) Earnings","media":"Simply Wall St.","content":"<div>\n<p>When close to half the companies in the United States have price-to-earnings ratios (or \"P/E's\") below 19x, you may consider MiMedx Group, Inc. (NASDAQ:MDXG) as a stock to potentially avoid with its ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mdxg/mimedx-group/news/investors-interested-in-mimedx-group-incs-nasdaqmdxg-earning\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investors Interested In MiMedx Group, Inc.'s (NASDAQ:MDXG) Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvestors Interested In MiMedx Group, Inc.'s (NASDAQ:MDXG) Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-09 19:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mdxg/mimedx-group/news/investors-interested-in-mimedx-group-incs-nasdaqmdxg-earning><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>When close to half the companies in the United States have price-to-earnings ratios (or \"P/E's\") below 19x, you may consider MiMedx Group, Inc. (NASDAQ:MDXG) as a stock to potentially avoid with its ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mdxg/mimedx-group/news/investors-interested-in-mimedx-group-incs-nasdaqmdxg-earning\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ISBC","symbol_name":"投资者银行","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mdxg/mimedx-group/news/investors-interested-in-mimedx-group-incs-nasdaqmdxg-earning","article_id":"2602215320","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mdxg/mimedx-group/news/investors-interested-in-mimedx-group-incs-nasdaqmdxg-earning","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2602215320","pubTimestamp":1767956804,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"When close to half the companies in the United States have price-to-earnings ratios (or \"P/E's\") below 19x, you may...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ISBC":"投资者银行","MDXG":"MiMedx Group, Inc.",".IXIC":"NASDAQ Composite"},"translate_title":"对MiMedx Group, Inc.（纳斯达克股票代码：MDXG）收益感兴趣的投资者","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDXG":1.5,"ISBC":1.5,".IXIC":1.5},"content_text":"When close to half the companies in the United States have price-to-earnings ratios (or \"P/E's\") below 19x, you may consider MiMedx Group, Inc. (NASDAQ:MDXG) as a stock to potentially avoid with its 22.9x P/E ratio.  However, the P/E might be high for a reason and it requires further investigation to determine if it's justified.    We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.  While the market has experienced earnings growth lately, MiMedx Group's earnings have gone into reverse gear, which is not great.   One possibility is that the P/E is high because investors think this poor earnings performance will turn the corner.  You'd really hope so, otherwise you're paying a pretty hefty price for no particular reason.     View our latest analysis for MiMedx Group NasdaqCM:MDXG Price to Earnings Ratio vs Industry January 9th 2026 Keen to find out how analysts think MiMedx Group's future stacks up against the industry? In that case, our free report is a great place to start. Advertisement Does Growth Match The High P/E?   MiMedx Group's P/E ratio would be typical for a company that's expected to deliver solid growth, and importantly, perform better than the market.   Taking a look back first, the company's earnings per share growth last year wasn't something to get excited about as it posted a disappointing decline of 51%.   This has erased any of its gains during the last three years, with practically no change in EPS being achieved in total.  Accordingly, shareholders probably wouldn't have been overly satisfied with the unstable medium-term growth rates.     Shifting to the future, estimates from the five analysts covering the company suggest earnings should grow by 25% per annum over the next three years.  With the market only predicted to deliver 12% each year, the company is positioned for a stronger earnings result.  With this information, we can see why MiMedx Group is trading at such a high P/E compared to the market.  Apparently shareholders aren't keen to offload something that is potentially eyeing a more prosperous future.    The Final Word  Using the price-to-earnings ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.  We've established that MiMedx Group maintains its high P/E on the strength of its forecast growth being higher than the wider market, as expected.  At this stage investors feel the potential for a deterioration in earnings isn't great enough to justify a lower P/E ratio.  Unless these conditions change, they will continue to provide strong support to the share price.      You always need to take note of risks, for example - MiMedx Group has 2 warning signs   we think you should be aware of.   You might be able to find a better investment than MiMedx Group. If you want a selection of possible candidates, check out this free list of interesting companies that trade on a low P/E (but have proven they can grow earnings). New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2602215320","isCrawlerRequest":true}